NCT07166653 Hospital-at-Home Education as Implementation Tool - RCT
| NCT ID | NCT07166653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nordsjaellands Hospital |
| Condition | Hospital |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14 participants in total. It began in 2025-09-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To enhance implementation of Hospital-at-home (HaH) in Scandinavia, the Nordic Digital Health \& Education (NorDigHE) project has developed a comprehensive virtual education on HaH for clinical staff. The goal of this clinical trial is to evaluate whether an online education for clinical staff can enhance the implementation of HaH services in hospitals across Denmark, Norway, and Sweden. The primary outcome of the RCT is HaH implementation measured at organization level, understood as a change in clinical practice by increased HaH activity. Secondary outcomes are HaH knowledge and motivation among clinical staff as well as patient days in hospital, days hospitalized at home, 30-day readmission, and mortality. Researchers will compare hospitals receiving the NorDigHE education (intervention group) to hospitals continuing treatment as usual (control group) to see if the education leads to greater adoption of HaH and changes in service delivery. Participants will: * Complete baseline, 3-month, and 6-month surveys assessing HaH activity, staff knowledge, and motivation. * Participate in a 12-month follow-up assessment (intervention group only). * Be invited (patients, staff, and management) to take part in semi-structured interviews to share experiences and preferences related to HaH. * (For staff in the intervention group) Complete the NorDigHE virtual education program embedded in the WHO Fast-IM. After the study, the control group will be offered access to the NorDigHE education as a participant retention measure.
Eligibility Criteria
Inclusion criteria: Hospitals with clinical departments treating acutely ill in-patients that have, or are ready to establish, the prerequisites and infrastructure for HaH - regardless of the specific approach, envisioned HaH model, primary sector collaborations, or local sector collaboration agreements and frameworks. Each hospital must have or be ready to establish: 1. a governance structure to organize and oversee HaH-services. 2. an IT-platform capable of managing data from and to HaH patients. 3. a safe communication pathway between HaH-patient and the hospital. 4. clear agreements on types of data to be exchanged between HaH-patient and hospital. 5. agreements on roles, responsibilities, and capacity (incl. possibly primary sector entities). 6. clinical guidelines, standard operating procedures, and action plans to support the HaH work. Exclusion Criteria: * Hospitals that do not have or are not ready to secure relevant pre-requisites listed above (a to f).
Contact & Investigator
Thea K Fischer
PRINCIPAL INVESTIGATOR
Forskningsafdelingen, Nordsjællands Hospital
Frequently Asked Questions
Who can join the NCT07166653 clinical trial?
This trial is open to participants of all sexes, studying Hospital. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07166653 currently recruiting?
Yes, NCT07166653 is actively recruiting participants. Contact the research team at mie.hjort.martinussen@regionh.dk for enrollment information.
Where is the NCT07166653 trial being conducted?
This trial is being conducted at Hillerød, Denmark, Fredrikstad, Norway, Göteborg, Sweden.
Who is sponsoring the NCT07166653 clinical trial?
NCT07166653 is sponsored by Nordsjaellands Hospital. The principal investigator is Thea K Fischer at Forskningsafdelingen, Nordsjællands Hospital. The trial plans to enroll 14 participants.